Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Treatment challenges in axial spondylarthritis and future directions.

Sieper J.

Curr Rheumatol Rep. 2013 Sep;15(9):356. doi: 10.1007/s11926-013-0356-9. Review.

PMID:
23888365
2.

Developments in therapies for spondyloarthritis.

Sieper J.

Nat Rev Rheumatol. 2012 Apr 10;8(5):280-7. doi: 10.1038/nrrheum.2012.40. Review.

PMID:
22487798
3.

Adalimumab for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis - a five-year update.

Poddubnyy D, Rudwaleit M.

Expert Opin Biol Ther. 2013 Nov;13(11):1599-611. doi: 10.1517/14712598.2013.839653. Epub 2013 Sep 27. Review.

PMID:
24074224
4.

Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).

Kroon FP, van der Burg LR, Ramiro S, Landewé RB, Buchbinder R, Falzon L, van der Heijde D.

Cochrane Database Syst Rev. 2015 Jul 17;(7):CD010952. doi: 10.1002/14651858.CD010952.pub2. Review.

PMID:
26186173
6.

The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis.

Deodhar A, Strand V, Kay J, Braun J.

Ann Rheum Dis. 2016 May;75(5):791-4. doi: 10.1136/annrheumdis-2015-208852. Epub 2016 Jan 14. Review.

PMID:
26768406
7.

Treatment of spondyloarthritis beyond TNF-alpha blockade.

Van den Bosch F, Deodhar A.

Best Pract Res Clin Rheumatol. 2014 Oct;28(5):819-27. doi: 10.1016/j.berh.2014.10.019. Epub 2014 Nov 18. Review.

PMID:
25488787
8.

Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.

Callhoff J, Sieper J, Weiß A, Zink A, Listing J.

Ann Rheum Dis. 2015 Jun;74(6):1241-8. doi: 10.1136/annrheumdis-2014-205322. Epub 2014 Apr 9. Review.

PMID:
24718959
9.

Can we reduce the dosage of biologics in spondyloarthritis?

Olivieri I, D'Angelo S, Padula A, Leccese P, Nigro A, Palazzi C.

Autoimmun Rev. 2013 May;12(7):691-3. doi: 10.1016/j.autrev.2012.08.013. Epub 2012 Aug 23. Review.

PMID:
22940233
10.

Efficacy of anti-TNF in patients with spondyloarthritis in absence of any imaging sign.

Bisson-Vaivre A, Alcaix D, Zarnitsky C, Pueyo L, Daragon A, Lanfant-Weybel K, Dacher JN, Vittecoq O, Le Loët X, Goëb V.

Joint Bone Spine. 2013 May;80(3):280-6. doi: 10.1016/j.jbspin.2012.08.003. Epub 2012 Sep 26.

PMID:
23021158
11.

Treatment with tumor necrosis factor inhibitors in axial spondyloarthritis: comparison between private rheumatology practices and academic centers in a large observational cohort.

Ciurea A, Weber U, Stekhoven D, Scherer A, Tamborrini G, Bernhard J, Toniolo M, Villiger PM, Zufferey P, Kissling RO, Michel BA, Exer P; Rheumatologists of Swiss Clinical Quality Management..

J Rheumatol. 2015 Jan;42(1):101-5. doi: 10.3899/jrheum.140229. Epub 2014 Nov 1.

PMID:
25362654
12.

Therapeutic controversies in spondyloarthritis: nonsteroidal anti-inflammatory drugs.

Poddubnyy D, van der Heijde D.

Rheum Dis Clin North Am. 2012 Aug;38(3):601-11. doi: 10.1016/j.rdc.2012.08.005. Epub 2012 Sep 15. Review.

PMID:
23083758
13.

Anti-TNFs in axial spondyloarthritis.

Kocijan R, Muschitz C, Rech J.

Wien Med Wochenschr. 2015 Jan;165(1-2):10-3. doi: 10.1007/s10354-014-0338-1. Epub 2015 Jan 9. Review.

PMID:
25572548
14.

Unanswered questions in the management of axial spondyloarthritis: an opinion piece.

Baraliakos X, Deodhar A.

Clin Rheumatol. 2014;33(10):1359-65. doi: 10.1007/s10067-014-2724-x. No abstract available.

PMID:
24941929
15.

Current therapeutics for spondyloarthritis.

Toussirot É.

Expert Opin Pharmacother. 2011 Nov;12(16):2469-77. doi: 10.1517/14656566.2011.604313. Review.

PMID:
21988214
16.

Tumor necrosis factor alpha antagonists in the treatment of axial spondyloarthritis.

Braun J, Baraliakos X, Heldmann F, Kiltz U.

Expert Opin Investig Drugs. 2014 May;23(5):647-59. doi: 10.1517/13543784.2014.899351. Epub 2014 Mar 22. Review.

PMID:
24654630
17.

How important is early therapy in axial spondyloarthritis?

Sieper J, Braun J.

Rheum Dis Clin North Am. 2012 Aug;38(3):635-42. doi: 10.1016/j.rdc.2012.08.001. Epub 2012 Sep 13. Review.

PMID:
23083760
18.

Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study.

Lubrano E, Perrotta FM, Marchesoni A, D'Angelo S, Ramonda R, Addimanda O, Olivieri I, Punzi L, Salvarani C.

J Rheumatol. 2015 Feb;42(2):258-63. doi: 10.3899/jrheum.140811. Epub 2014 Dec 15.

PMID:
25512483
19.

[The pharmacotherapy of spondyloarthritis].

Curković B.

Reumatizam. 2011;58(2):65-8. Review. Croatian.

PMID:
22232952
20.

Efficacy, safety and cost per responder of biologics in the treatment of non-radiographic axial spondyloarthritis.

Olivieri I, Fanizza C, Gilio M, Ravasio R.

Clin Exp Rheumatol. 2016 Sep-Oct;34(5):935-940. Epub 2016 Jul 4. Review.

Supplemental Content

Support Center